Suchergebnisse - "Căruntu, Florin Alexandru"

PubPharm (35)

1

Hepatitis D virus infection : Pathophysiology, epidemiology and treatment. Report from the first international delta cure meeting 2022

enthalten in: JHEP reports : innovation in hepatology | 2023

von Lampertico, P. | Degasperi, E. | Sandmann, L. | +24

2

Quality-of-life scores improve after 96 weeks of PEG-IFNa-2a treatment of hepatitis D : An analysis of the HIDIT-II trial

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2023

von Dinkelborg, K. | Kahlhöfer, J. | Dörge, P. | +29

3

Quality‐of‐life scores improve after 96 weeks of PEG‐IFNa‐2a treatment of hepatitis D : An analysis of the HIDIT‐II trial

enthalten in: Liver International | 2023

von Dinkelborg, K. | Kahlhöfer, J. | Dörge, P. | +28

4

Residual low HDV viraemia is associated HDV RNA relapse after PEG-IFNa-based antiviral treatment of hepatitis delta : Results from the HIDIT-II study

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2021

von Bremer, B. | Anastasiou, O. | Hardtke, S. | +15

5

A transient early HBV-DNA increase during PEG-IFNα therapy of hepatitis D indicates loss of infected cells and is associated with HDV-RNA and HBsAg reduction

enthalten in: Journal of viral hepatitis | 2021

von Anastasiou, O. | Yurdaydin, C. | Maasoumy, B. | +17

6

A transient early HBV‐DNA increase during PEG‐IFNα therapy of hepatitis D indicates loss of infected cells and is associated with HDV‐RNA and HBsAg reduction

enthalten in: Journal of Viral Hepatitis | 2021

von Anastasiou, O. | Yurdaydin, C. | Maasoumy, B. | +17

7

Residual low HDV viraemia is associated HDV RNA relapse after PEG‐IFNa‐based antiviral treatment of hepatitis delta : Results from the HIDIT‐II study

enthalten in: Liver International | 2021

von Bremer, B. | Anastasiou, O. | Hardtke, S. | +15

8

Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II) : a randomised, placebo controlled, phase 2 trial

enthalten in: The Lancet. Infectious diseases | 2019

von Wedemeyer, H. | Yurdaydin, C. | Hardtke, S. | +25

CommentIn: Lancet Infect Dis. 2019 Mar;19(3):221-222. - PMID 30833048

9

Primary peritoneal tuberculosis, a forgotten localization. Case report

enthalten in: The Indian journal of tuberculosis | 2018

von Buinoiu, N. | Enache, S. | Chirculescu, B. | +7

10

Efficacy and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with ribavirin for the treatment of HCV genotype 1b compensated cirrhosis in patients aged 70 years or older

enthalten in: Medicine | 2017

von Trifan, A. | Stanciu, C. | Gheorghe, L. | +16